NovaResp Technologies
Halifax medical software company developing cMAP, machine-learning software for positive airway pressure machines that predicts apnea events before they occur. cMAP is investigational and not yet commercially available.
Canadian innovation builds a brighter tomorrow.
About
Company site: novaresp.aiHalifax medical software company developing cMAP, machine-learning software for positive airway pressure machines that predicts apnea events before they occur. cMAP is investigational and not yet commercially available.
States cMAP "uses artificial intelligence and machine learning during PAP therapy to predict and prevent episodes of apnea before they occur". novaresp.ai
Its own site states cMAP is "an investigational technology still under development and not yet commercially available". novaresp.ai
Holds granted US patent 11,413,414 for a method and apparatus for breathing assistance, filed 2017 with a 2016 priority date. patents.google.com
Sponsors registered clinical studies in Halifax, including a 200-participant trial on adherence to proactive sleep apnea therapy. clinicaltrials.gov
Named Innovative Business of the Year at the 2025 Halifax Business Awards. halifaxchamber.com
Company address is 54-1344 Summer Street, Halifax, Nova Scotia. novaresp.ai
Government & Grants
Government support actually received. Unpublished amounts are left out.
Industrial Research Assistance Program, National Research Council Canada
Regional Economic Growth through Innovation, Atlantic Canada Opportunities Agency
People
Sourced from the company's own pages or announcements.
Hamed Hanafi
Founder and Chief Executive Officer
Bill Power
Director of Operations
Technology Focus
Company site: novaresp.aiTerms the company uses about its own work.
Similar Companies
Other companies in Digital Health & HealthTech.
